<?xml version="1.0" encoding="UTF-8"?>
<p>Previous modelling studies and empiric data indicate that DAA scale-up has the potential to curb the HCV epidemic among HIV-positive MSM [
 <xref rid="CIT0012" ref-type="bibr">12â€“15</xref>]. Our results suggest that for a successful treatment-as-prevention approach and a correct interpretation of its effects, international transmission should be considered, and that targeted joint European scale-up schemes may increase the efficiency of such interventions.
</p>
